InvestorsHub Logo
Followers 14
Posts 2855
Boards Moderated 0
Alias Born 12/23/2014

Re: Paullee post# 1030

Tuesday, 10/19/2021 11:02:06 AM

Tuesday, October 19, 2021 11:02:06 AM

Post# of 1140
Paulee,
Got any thoughts on this? From an 8K released yesterday.

Sorrento Therapeutics, Inc. (“Sorrento”) and Dyadic International (USA), Inc. (“Dyadic”) have not executed the License Agreement within the forty-five business day time period set forth in the Term Sheet For Intellectual Property License Agreement by and between Sorrento and Dyadic, dated August 10, 2021 (the “Term Sheet”). The parties are continuing to discuss and negotiate certain matters relating to certain provisions of the License Agreement. Unless and until the open matters are resolved, Dyadic can give no guidance if or when the License Agreement will be executed. In the interim, other activities, including technology transfer to Sorrento relating to DYAI-100 and C1, will continue under the provisions of the Term Sheet, which is binding on both parties and which continues until the execution of the License Agreement.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News